Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-18 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |